New Ultra-Sensitive Assays Aim to Improve Early Detection of Alzheimer’s and Parkinson’s Disease
Three new immunoassays targeting key neurodegeneration biomarkers require just 1 µL of plasma and run on standard laboratory instruments.
Three new immunoassays targeting key neurodegeneration biomarkers require just 1 µL of plasma and run on standard laboratory instruments.
Revvity, Inc. has launched the IDS i20, a fully automated, high-throughput platform for ChLIA, enabling labs to consolidate specialty tests.
bioMérieux has received FDA 510(k) clearance for VITEK COMPACT PRO, aimed at improving diagnostics in clinical and industrial laboratories.
Beckman Coulter expanded the menu of assays for its DxI 9000 Access Immunoassay Analyzer with the recent CE marking of hepatitis tests.
Abbott's Alere NT-proBNP assay for Alinity i is a new tool for heart failure diagnosis, providing accurate results and improved efficiency.
Having high-quality assays, molecular controls, and automated workflow solutions are critical in...